CardioPrecision Makes Global Breakthrough In Robot-Assisted Heart Surgery
13.03.2024
CardioPrecision has played a leading role in bringing the world’s FIRST robotic aortic valve replacement through a tiny incision in the neck significantly closer to reality.
CardioPrecision recently demonstrated a proof-of-concept AVATAR (Advanced Videoscopic Aortic valve surgery by Transcervical Approach using Robot assistance) proc...
Read More
CardioPrecision Ltd Founder/CMO Awarded at ISMICS 2023
08.06.2023
CardioPrecision Founder and Chief Medical Officer Mr Fraser Sutherland has been honoured with a prestigious award at the 2023 ISMICS annual meeting in Boston, MA, USA.
The International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) annual meeting gathers pioneers, experts, and like-m...
Read More
CardioPrecision – Finalist for prestigious Scottish Life Sciences Awards
31.01.2023
CardioPrecision is proud to announce that it has received a nomination for an award at the Scotland’s Life Sciences Annual Awards.
CardioPrecision is one of three finalists under the Innovation - Health technology Category.
Scotland's Life Scie...
Read More
CardioPrecision Announces New Investment
31.10.2022
CardioPrecision Ltd, a technology company focussed on less invasive treatment of structural heart disease and cardiothoracic interventions, has received new investment. The equity financing was led by existing investors, principally London & Scottish Investment Partners, Discovery Investment Fund and Scottish Enterprise.
CardioPrec...
Read More
CardioPrecision Enters US Market
05.08.2022
CardioPrecision announces entry into the US market with its CoreVista® devices for use in Endoscopic Vessel Harvesting (EVH).
Coincident with the recent investment funding round, CardioPrecision performed first US cases at the prestigious Massachusetts General Hospital, in Boston, using its patented CoreVista® suite of devices.
Re...
Read More
CardioPrecision Launches CoreVista® Devices for Endoscopic Vessel Harvesting (EVH)
01.09.2021
CardioPrecision Ltd, a technology company developing medical devices for the treatment of structural heart disease and cardiothoracic interventions, has recently launched its suite of CoreVista® devices for use in Endoscopic Vessel Harvesting (EVH) during coronary artery bypass grafting (CABG) surgery.
EVH is a technique whereby bypass conduits are harvested endoscopically from the limbs thro...
Read More
CardioPrecision Secures Further Investment
24.07.2020
CardioPrecision Ltd, the global leader in transcervical access for the treatment of structural heart disease and cardiothoracic interventions, received further investment. The equity financing was led by existing investors and the Scottish Investment Bank, the investment arm of Scottish Enterprise.
CardioPrecision’s patented CoreVista® Technology facilitates access to the chest through a sho...
Read More
CardioPrecision Announces New TMVR Method Patent in the US
08.10.2019
CardioPrecision Ltd, the global leader in transcervical access for the treatment of structural heart disease and cardiothoracic intervention, announces the issuance of its latest patent ‘New Method and System for Transcatheter Intervention’ from the United States Patent and Trademark Office.
CardioPrecision Founder and Chief Medical Officer, Mr Fraser Sutherland, MD, commented: “ We are ...
Read More
CardioPrecision Secures Further Investment
13.09.2019
CardioPrecision Ltd, the global leader in transcervical access for the treatment of structural heart disease and cardiothoracic intervention, successfully completed a further funding round from existing angel investors and Scottish Enterprise.
“The success in raising this funding round in record time from the existing investors is a dramatic endorsement of the strength of the Company’s tran...
Read More
CardioPrecision Founders Awarded Prestigious Cutler’s Surgical Prize 2019
13.03.2019
Founders of CardioPrecision Ltd, the global leader in transcervical access for the treatment of structural heart disease and cardiothoracic intervention, received the closely coveted and prestigious Cutler’s Surgical Prize.
CardioPrecision Founders Dr Ying Sutherland, PhD, and Mr Fraser Sutherland, MD, are honoured with award of the prestigious Cutler’s Surgical Prize by the Worshipful Comp...
Read More